AACR 2023 Conference Coverage
J

A Personalized Cancer Vaccine mRNA-4157 + Pembro vs. Pembro in Resected HR-Melanoma: Efficacy & Safety Results From the Randomized, Open-Label Phase 2 mRNA-4157-P201/KEYNOTE-942 Trial

By AACR 2023 Conference Coverage FEATURING Jeffrey Weber
By AACR 2023 Conference Coverage FEATURING Jeffrey Weber
341 views
May 9, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

20:09

Dysplastic Nevi: Navigating the Risk Landscape

Scripps Health

B. Kelley

1.9K views

·

8 months ago
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

·

7 months ago
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

798 views

·

8 months ago
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

759 views

·

4 months ago
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

999 views

·

8 months ago
09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

271 views

·

3 months ago
10:22

mRNA Vaccine in Treatment of Pancreatic Cancer

Houston Methodist

J. Gonzalez

932 views

·

1 year ago
09:00

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

740 views

·

7 months ago
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

700 views

·

4 months ago
27:38

Sun Safety and Melanoma Awareness: Expert Tips on Preventing Sun Dam…

Oncology Data Advisor

T. Knight, M. Hadfield

200 views

·

2 months ago
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

467 views

·

5 months ago
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

511 views

·

4 months ago
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

460 views

·

4 months ago
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

387 views

·

5 months ago
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views

·

4 months ago
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

192 views

·

1 month ago
18:28

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

400 views

·

6 months ago
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

325 views

·

4 months ago
11:27

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

274 views

·

4 months ago
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

323 views

·

3 months ago
AUTOPLAY